Cara Therapeutics to Webcast Presentation at 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference
March 13 2015 - 8:00AM
Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company
focused on developing and commercializing new chemical entities
designed to alleviate pain and pruritus by selectively targeting
kappa opioid receptors, today announced that Dr. Derek Chalmers,
President and CEO, will present a company overview at the 22nd
Annual BioCentury Future Leaders in the Biotech Industry Conference
on Friday, March 20, 2015, at 2:00 p.m. ET in New York City.
A live webcast of the presentation can be accessed under "Events
and Presentations" in the News & Investors section of the
Company's website at www.CaraTherapeutics.com. An archived webcast
recording will be available on the Cara website for approximately
30 days.
About Cara Therapeutics
Cara Therapeutics is a clinical-stage biopharmaceutical company
focused on developing and commercializing new chemical entities
designed to alleviate pain and pruritus by selectively targeting
kappa opioid receptors. Cara is developing a novel and proprietary
class of product candidates that target the body's peripheral
nervous system and have demonstrated efficacy in patients with
moderate-to-severe pain without inducing many of the undesirable
side effects typically associated with currently available pain
therapeutics.
CONTACT: INVESTOR CONTACT:
Jesse Baumgartner
Stern Investor Relations, Inc.
212-362-1200
Jesse@sternir.com
MEDIA CONTACT:
Annie Starr
6 Degrees
973-415-8838
astarr@6degreespr.com
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Jul 2023 to Jul 2024